1) The clinical development of reformulated natural based medicines for the treatment of unmet needs in oncology and infectious diseases.
2) The development of synthetic formulations of currently existing drugs with a specific focus on the potential third wave of drug policy reform.
Our foundation is built upon 2 core pillars.
